Table 5.
Other outcome parameters
| Studies, n | Included patients, n | Outcome, n (%) | |
|---|---|---|---|
| Mortality rate | |||
| Conservative | 6 | 78 | 9 (12%) |
| Endoscopic | |||
| Stent | 7 | 76 | 11 (14%) |
| Drainage | 4 | 95 | 8 (8%) |
| Endoscopic VAC | 1 | 5 | 0 (0%) |
| Dilatation | 2 | 13 | 0 (0%) |
| Surgical | 1 | 6 | 3 (50%) |
| Success rate | |||
| Conservative | 6 | 78 | 69 (88%) |
| Endoscopic | |||
| Stent | 7 | 76 | 57 (75%) |
| Drainage | 4 | 95 | 86 (91%) |
| Endoscopic VAC | 1 | 5 | 5 (100%) |
| Dilatation | 2 | 13 | 13 (100%) |
| Surgical | 1 | 6 | 3 (50%) |
| Severe complications | |||
| Conservative | 4 | 56 | 9 (16%) |
| Endoscopic | |||
| Stent | 6 | 58 | 27 (47%) |
| Drainage | 3 | 72 | 13 (18%) |
| Endoscopic VAC | NA | NA | |
| Dilatation | 2 | 13 | 5 (38%) |
| Surgical | 1 | 6 | 3 (50%) |
| Reinterventions | |||
| Conservative | 2 | 36 | 5 (36%) |
| Endoscopic | |||
| Stent | 6 | 67 | 27 (40%) |
| Drainage | 2 | 47 | 10 (21%) |
| Endoscopic VAC | NA | NA | NA |
| Dilatation | 2 | 13 | 5 (38%) |
| Surgical | NA | NA | NA |
| Mean number of reinterventions | |||
| Conservative | 2 | 36 | 3 |
| Endoscopic | |||
| Stent | 6 | 67 | 1 |
| Drainage | 2 | 47 | 1 |
| Endoscopic VAC | NA | NA | NA |
| Dilatation | 2 | 13 | 4 |
| Surgical | NA | NA | NA |
| Reoperations | |||
| Conservative | 3 | 53 | 2 (4%) |
| Endoscopic | |||
| Stent | 4 | 46 | 6 (13%) |
| Drainage | 1 | 23 | 1 (4%) |
| Endoscopic VAC | NA | NA | NA |
| Dilatation | NA | NA | NA |
| Surgical | 1 | 6 | 2 (33%) |
| Hospital length of stay | |||
| Conservative | 4 | 65 | 41 days |
| Endoscopic | |||
| Stent | 4 | 51 | 37 days |
| Drainage | 2 | 48 | 42 days |
| Endoscopic VAC | NA | NA | NA |
| Dilatation | NA | NA | NA |
| Surgical | NA | NA | NA |
| ICU length of stay | |||
| Conservative | 2 | 40 | 16 days |
| Endoscopic | |||
| Stent | 1 | 9 | 25 days |
| Drainage | 1 | 23 | 12 days |
| Endoscopic VAC | NA | NA | NA |
| Dilatation | NA | NA | NA |
| Surgical | NA | NA | NA |
VAC vacuum-assisted closure, NA not available